These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 15222694
1. Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment. Liuzzi GM, Latronico T, Fasano A, Carlone G, Riccio P. Mult Scler; 2004 Jun; 10(3):290-7. PubMed ID: 15222694 [Abstract] [Full Text] [Related]
2. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia. Liuzzi GM, Mastroianni CM, Latronico T, Mengoni F, Fasano A, Lichtner M, Vullo V, Riccio P. Brain; 2004 Feb; 127(Pt 2):398-407. PubMed ID: 14662518 [Abstract] [Full Text] [Related]
3. Inhibition of myelin-cleaving poteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. Latronico T, Branà MT, Gramegna P, Fasano A, Di Bari G, Liuzzi GM. PLoS One; 2013 Feb; 8(2):e49656. PubMed ID: 23390485 [Abstract] [Full Text] [Related]
4. In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection. Gramegna P, Latronico T, Branà MT, Di Bari G, Mengoni F, Belvisi V, Mascellino MT, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM. PLoS One; 2011 Feb; 6(12):e28499. PubMed ID: 22174822 [Abstract] [Full Text] [Related]
5. Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatment. Liuzzi GM, Latronico T, Rossano R, Viggiani S, Fasano A, Riccio P. Neurochem Res; 2007 Dec; 32(12):2184-93. PubMed ID: 17624613 [Abstract] [Full Text] [Related]
6. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A. Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495 [Abstract] [Full Text] [Related]
7. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F. J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607 [Abstract] [Full Text] [Related]
8. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. Brain Res; 2001 Mar 02; 893(1-2):104-12. PubMed ID: 11222998 [Abstract] [Full Text] [Related]
9. Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures. Di Bari G, Gentile E, Latronico T, Corriero G, Fasano A, Nonnis Marzano C, Liuzzi GM. PLoS One; 2015 Mar 02; 10(6):e0129322. PubMed ID: 26053757 [Abstract] [Full Text] [Related]
10. A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Crocker SJ, Frausto RF, Whitton JL, Milner R. Glia; 2008 Aug 15; 56(11):1187-98. PubMed ID: 18449943 [Abstract] [Full Text] [Related]
11. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. Welser-Alves JV, Crocker SJ, Milner R. J Neuroinflammation; 2011 Jun 01; 8():61. PubMed ID: 21631912 [Abstract] [Full Text] [Related]
12. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Liuzzi GM, Latronico T, Branà MT, Gramegna P, Coniglio MG, Rossano R, Larocca M, Riccio P. Neurochem Res; 2011 Mar 01; 36(3):518-27. PubMed ID: 21207142 [Abstract] [Full Text] [Related]
13. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Gilli F, Bertolotto A, Sala A, Hoffmann F, Capobianco M, Malucchi S, Glass T, Kappos L, Lindberg RL, Leppert D. Brain; 2004 Feb 01; 127(Pt 2):259-68. PubMed ID: 14607790 [Abstract] [Full Text] [Related]
14. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients. Bernal F, Elias B, Hartung HP, Kieseier BC. Mult Scler; 2009 Jun 01; 15(6):721-7. PubMed ID: 19383643 [Abstract] [Full Text] [Related]
15. Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis. Galboiz Y, Shapiro S, Lahat N, Miller A. J Neuroimmunol; 2002 Oct 01; 131(1-2):191-200. PubMed ID: 12458052 [Abstract] [Full Text] [Related]
16. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. Woo MS, Park JS, Choi IY, Kim WK, Kim HS. J Neurochem; 2008 Jul 01; 106(2):770-80. PubMed ID: 18419763 [Abstract] [Full Text] [Related]